Cargando…
Single-cell transcriptome analysis reveals T-cell exhaustion in denosumab-treated giant cell tumor of bone
Denosumab (DMAB), a human monoclonal antibody against the receptor activator of the nuclear factor-kappa B ligand, is used for the treatment for unresectable giant cell tumor of bone (GCTB). However, little is known about the molecular and functional characteristics of GCTB-infiltrating lymphocytes...
Autores principales: | Yang, Meiling, Wang, Fen, Lu, Guohao, Cheng, Mingzhe, Zhao, Wei, Zou, Changye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510370/ https://www.ncbi.nlm.nih.gov/pubmed/36172351 http://dx.doi.org/10.3389/fimmu.2022.934078 |
Ejemplares similares
-
Single-Cell Transcriptome Analysis Reveals RGS1 as a New Marker and Promoting Factor for T-Cell Exhaustion in Multiple Cancers
por: Bai, Yunmeng, et al.
Publicado: (2021) -
A Recurrent Giant Cell Tumor of Bone Treated with Denosumab
por: Stadler, Nicola, et al.
Publicado: (2015) -
Single-Cell Transcriptomics of Immune Cells Reveal Diversity and Exhaustion Signatures in Non-Small-Cell Lung Cancer
por: Zhao, Ying, et al.
Publicado: (2022) -
Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab
por: Hakozaki, Michiyuki, et al.
Publicado: (2014) -
Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab
por: Mukaihara, Kenta, et al.
Publicado: (2016)